isoxazoles has been researched along with Carcinoma, Neuroendocrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhefdhi, A; Burke, JF; Chen, H; Kunnimalaiyaan, M; Redlich, A | 1 |
| Ailer, G; Auernhammer, CJ; Beuschlein, F; Göke, B; Maurer, J; Spoettl, G; Vlotides, G; Zitzmann, K | 1 |
2 other study(ies) available for isoxazoles and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Leflunomide suppresses growth in human medullary thyroid cancer cells.
Topics: Antineoplastic Agents; Antirheumatic Agents; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Dose-Response Relationship, Drug; Down-Regulation; Humans; Isoxazoles; Leflunomide; Thyroid Neoplasms | 2013 |
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Pancreatic Neoplasms; Phosphoproteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Pyridones; Pyrimidines; Receptor, ErbB-2; Receptor, IGF Type 1; Resorcinols; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction | 2013 |